findmyKOL

Amir Jazaeri, MD

Enriched profile

Professor, Gynecologic Oncology and Reproductive Medicine; Vice Chair for Clinical Research; Director, Gynecologic Cancer Immunotherapy Program · The University of Texas MD Anderson Cancer Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyGynecologic OncologyFocusOvarian cancer diagnosis and treatment+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2025–2026

Amir Jazaeri is Professor, Gynecologic Oncology and Reproductive Medicine; Vice Chair for Clinical Research; Director, Gynecologic Cancer Immunotherapy Program at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 488 publications with 9,085 citations (h-index 44); ClinicalTrials.gov lists 21 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 24 Oct 2026

Amir Jazaeri, MD, is Professor, Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. The public record shows 488 publications with 9,085 citations (h-index 44), centered on Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, Endometrial and Cervical Cancer Treatments. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 17 companies, 1 NIH-funded awards (2025–2026).

  • Most recent indexed publication: 2026 · Nature communications
  • Top research focus: Ovarian cancer diagnosis and treatment
  • 21 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Ovarian / Gynecologic Cancer11 trialsFallopian Tube Neoplasms4 trialsSarcoma2 trialsComa2 trialsCarcinosarcoma2 trialsUterine Cervical Neoplasms2 trialsEndometrial Neoplasms2 trialsAdenocarcinoma, Clear Cell2 trialsBreast Cancer1 trialCarcinoma, Squamous Cell1 trialChondrosarcoma1 trialGiant Cell Tumor of Bone1 trialPeritoneal Neoplasms1 trialCarcinoma, Endometrioid1 trialPancreatic Cancer1 trialColorectal Cancer1 trialRectal Neoplasms1 trial

Research focus

OpenAlex concept fingerprint
Ovarian cancer diagnosis and treatmentCancer Immunotherapy and BiomarkersEndometrial and Cervical Cancer TreatmentsBRCA gene mutations in cancerImmunotherapy and Immune Responses

Drugs & molecules

across trials, industry payments and publications
Lynparzageneric · OlaparibClinical trials—Industry payments2Publications2Keytrudageneric · PembrolizumabClinical trials—Industry payments2Publications1AVMAPKI FAKZYNJA CO-PACKClinical trials—Industry payments2Publications—Elaheregeneric · Mirvetuximab soravtansineClinical trials—Industry payments2Publications—EVARRESTClinical trials—Industry payments2Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments2Publications—Exparelgeneric · BupivacaineClinical trials—Industry payments1Publications—Margenzageneric · MargetuximabClinical trials—Industry payments1Publications—Rubracageneric · RucaparibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
M.D. Anderson Cancer CenterClinical trials15Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Ethicon US, LLCClinical trials—Industry payments3Intuitive Surgical, Inc.Clinical trials—Industry payments3Alkermes, Inc.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Eisai Inc.Clinical trials—Industry payments2Stryker CorporationClinical trials—Industry payments2Verastem, Inc.Clinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1AstraZeneca UK LimitedClinical trials—Industry payments1Clovis Oncology, Inc.Clinical trials—Industry payments1ImmunoGen, Inc.Clinical trials—Industry payments1ImunonClinical trials1Industry payments—MacroGenicsClinical trials1Industry payments—Macrogenics, Inc.Clinical trials—Industry payments1Merck KGaAClinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1Merck Sharp & Dohme LLCClinical trials—Industry payments1Outpace Bio, Inc.Clinical trials1Industry payments—Pacira Pharmaceuticals IncorporatedClinical trials—Industry payments1Roswell Park Cancer InstituteClinical trials1Industry payments—Theolytics LimitedClinical trials1Industry payments—University of VirginiaClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
488publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

9,085citations

Total citations across indexed works.

44h-index

Hirsch index (OpenAlex). i10-index 106.

Clinical & industry

trials, payments and federal funding
21clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2025–2026

Federally funded research awards.

View funding ↓

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 24 Oct 2026

Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:

All 21 trial records: search, sort and filter.Explore →

Industry payments

Updated 24 Oct 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 20 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 24 Oct 2026

1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:

Congress activity

Updated 24 Oct 2026

87 congress contributions (2010–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:

All 87 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 24 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 22 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    Article2,003 citations2003
    doi.org ↗
  2. 02
    Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
    Article481 citations2023
    doi.org ↗
  3. 03
    Selective loss of estrogen receptor beta in malignant human colon.
    Article313 citations2000
    openalex.org ↗
  4. 04
    Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
    Article287 citations2002
    doi.org ↗
  5. 05
    Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
    Article267 citations2017
    doi.org ↗
All 488 cited works: search, sort and filter.Explore →

Network

Updated 24 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Shannon Neville Westin187Pamela T. Soliman128Karen H. Lu118Bryan M. Fellman110Nicole D. Fleming71Anil K. Sood67Ying Yuan64Anil K. Sood60Travis T. Sims59Robert Louis Coleman57Jeffrey How55Aaron Shafer52Larissa Alejandra Meyer51Barrett Craig Lawson51Lauren Patterson Cobb49Michael Frumovitz49David S. Hong45Lois Michelle Ramondetta45Gordon Brent Mills44Funda Meric‐Bernstam44Robert Tyler Hillman43David Marc Gershenson42Cara Haymaker41Elizabeth D. Euscher38Linghua Wang36Anne T. Knisely36Heather Yan Lin34Joseph Celestino33Anindya Dutta32Emily Hinchcliff32Amber M. Johnson32Amadeo B. Biter32Kathleen M. Schmeler32Mirella Nardo32Vijaykumar R. Holla32Erick Campbell31Ji Son31Yingao Zhang31Jinsong Liu31Ying Yuan30

Online presence

Updated 24 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/amir-jazaeri-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 24 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of Virginia School of Medicine

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • B.A.

    Interdisciplinary Studies, University of Virginia

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Board certified

    American Board of Obstetrics and Gynecology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗

Editorial & leadership roles

journal and society appointments
  • Member

    Editorial Review Board, Cancers

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Member

    Editorial Review Board, Gynecologic Oncology

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Study Section Member

    American Cancer Society Tumor Biology & Genetics

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Member

    Society of Gynecologic Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
  • Member

    American Society of Clinical Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.